Literature DB >> 8728533

Recent developments in anxiety, stress, and depression.

S E File1.   

Abstract

Recent research in the development, analysis, and pharmacology of animal tests of state anxiety is discussed, including the use of responses to predator odours, the role of learning in modifying the anxiety measured in the plus-maze, and the roles of cholinergic, NMDA, and dopaminergic systems. Developmental and genetic factors are considered with particular reference to the development of tests of trait anxiety. The roles of 5-HT1A receptors in anxiety, depression, impulsivitity, and agonistic behaviours are discussed. Recent studies on the impacts of stress on neurotransmitter, endocrine, and immune systems and the interactions between these systems are discussed, with particular emphasis on their contributions to the development of pathologic states relevant to anxiety and depression.

Entities:  

Mesh:

Year:  1996        PMID: 8728533     DOI: 10.1016/0091-3057(95)02175-2

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  9 in total

Review 1.  Recent progress in the synthesis and characterization of group II metabotropic glutamate receptor allosteric modulators.

Authors:  Douglas J Sheffler; Anthony B Pinkerton; Russell Dahl; Athina Markou; Nicholas D P Cosford
Journal:  ACS Chem Neurosci       Date:  2011-04-12       Impact factor: 4.418

2.  Locomotor response to novelty as a predictor of reactivity to aversive stimuli in the rat.

Authors:  David A White; Mikhail Kalinichev; Stephen G Holtzman
Journal:  Brain Res       Date:  2007-02-28       Impact factor: 3.252

3.  Serotonin receptor 1A knockout: an animal model of anxiety-related disorder.

Authors:  S Ramboz; R Oosting; D A Amara; H F Kung; P Blier; M Mendelsohn; J J Mann; D Brunner; R Hen
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

4.  Marble burying reflects a repetitive and perseverative behavior more than novelty-induced anxiety.

Authors:  Alexia Thomas; April Burant; Nghiem Bui; Deanna Graham; Lisa A Yuva-Paylor; Richard Paylor
Journal:  Psychopharmacology (Berl)       Date:  2009-02-03       Impact factor: 4.530

5.  Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice.

Authors:  L K Heisler; H M Chu; T J Brennan; J A Danao; P Bajwa; L H Parsons; L H Tecott
Journal:  Proc Natl Acad Sci U S A       Date:  1998-12-08       Impact factor: 11.205

6.  Social isolation in prairie voles induces behaviors relevant to negative affect: toward the development of a rodent model focused on co-occurring depression and anxiety.

Authors:  Angela J Grippo; Kevin D Wu; Iman Hassan; C Sue Carter
Journal:  Depress Anxiety       Date:  2008       Impact factor: 6.505

7.  Putative Epigenetic Involvement of the Endocannabinoid System in Anxiety- and Depression-Related Behaviors Caused by Nicotine as a Stressor.

Authors:  Tamaki Hayase
Journal:  PLoS One       Date:  2016-07-12       Impact factor: 3.240

8.  Serotoninergic receptor ligands improve Tamoxifen effectiveness on breast cancer cells.

Authors:  Maria Rosaria Ambrosio; Elisa Magli; Giuseppe Caliendo; Rosa Sparaco; Paola Massarelli; Vittoria D'Esposito; Teresa Migliaccio; Giusy Mosca; Ferdinando Fiorino; Pietro Formisano
Journal:  BMC Cancer       Date:  2022-02-15       Impact factor: 4.430

9.  Synthesis, Docking Studies and Pharmacological Evaluation of Serotoninergic Ligands Containing a 5-Norbornene-2-Carboxamide Nucleus.

Authors:  Rosa Sparaco; Ewa Kędzierska; Agnieszka A Kaczor; Anna Bielenica; Elisa Magli; Beatrice Severino; Angela Corvino; Ewa Gibuła-Tarłowska; Jolanta H Kotlińska; Giorgia Andreozzi; Paolo Luciano; Elisa Perissutti; Francesco Frecentese; Marcello Casertano; Anna Leśniak; Magdalena Bujalska-Zadrożny; Małgorzata Oziębło; Raffaele Capasso; Vincenzo Santagada; Giuseppe Caliendo; Ferdinando Fiorino
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.